Aliases & Classifications for Skin Conditions

MalaCards integrated aliases for Skin Conditions:

Name: Skin Conditions 38 43
Dermatologic Disorders 73

Classifications:



Summaries for Skin Conditions

MedlinePlus : 43 Your skin is your body's largest organ. It covers and protects your body. Your skin Holds body fluids in, preventing dehydration Keeps harmful microbes out, preventing infections Helps you feel things like heat, cold, and pain Keeps your body temperature even Makes vitamin D when the sun shines on it Anything that irritates, clogs, or inflames your skin can cause symptoms such as redness, swelling, burning, and itching. Allergies, irritants, your genetic makeup, and certain diseases and immune system problems can cause rashes, hives, and other skin conditions. Many skin problems, such as acne, also affect your appearance. NIH: National Institute of Arthritis and Musculoskeletal and Skin Diseases

MalaCards based summary : Skin Conditions, also known as dermatologic disorders, is related to contact dermatitis and dermatitis, and has symptoms including enanthema, exanthema and pruritus. An important gene associated with Skin Conditions is IL1A (Interleukin 1 Alpha), and among its related pathways/superpathways are Toll-like Receptor Signaling Pathway and Regulation of IFNA signaling. The drugs Tacrolimus and Metformin have been mentioned in the context of this disorder. Affiliated tissues include skin, breast and testes.

Related Diseases for Skin Conditions

Diseases related to Skin Conditions via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 117)
# Related Disease Score Top Affiliating Genes
1 contact dermatitis 29.7 IL1A TNF
2 dermatitis 10.8
3 irritant dermatitis 10.6 IL1A TNF
4 stachybotrys chartarum 10.6 IL1A TNF
5 multidrug-resistant tuberculosis 10.6 IL1A TNF
6 post-transplant lymphoproliferative disease 10.6 IL1A TNF
7 aseptic meningitis 10.5 IL1A TNF
8 pulpitis 10.5 IL1A TNF
9 idiopathic neutropenia 10.5 IL1A TNF
10 darier-white disease 10.5
11 immunodysregulation, polyendocrinopathy, and enteropathy, x-linked 10.5
12 erythroderma, ichthyosiform, congenital reticular 10.5
13 crouzon syndrome with acanthosis nigricans 10.5
14 nevoid hypermelanosis, linear and whorled 10.5
15 dowling-degos disease 10.5
16 scleredema 10.5
17 keratoconjunctivitis sicca 10.5 IL1A TNF
18 bacterial vaginosis 10.5 IL1A TNF
19 tonsillitis 10.5 IL1A TNF
20 aggressive periodontitis 10.5 IL1A TNF
21 silicosis 10.4 IL1A TNF
22 oligoarticular juvenile idiopathic arthritis 10.4 CD247 TNF
23 chorioamnionitis 10.4 IL1A TNF
24 pneumoconiosis 10.4 IL1A TNF
25 transient bullous dermolysis of the newborn 10.4
26 erythrokeratodermia variabilis et progressiva 1 10.4
27 skin creases, congenital symmetric circumferential, 1 10.4
28 nail disorder, nonsyndromic congenital, 1 10.4
29 benign chronic pemphigus 10.4
30 pityriasis rubra pilaris 10.4
31 porokeratosis 1, multiple types 10.4
32 rothmund-thomson syndrome 10.4
33 restrictive dermopathy, lethal 10.4
34 wiskott-aldrich syndrome 10.4
35 ichthyosis, x-linked 10.4
36 vitiligo-associated multiple autoimmune disease susceptibility 1 10.4
37 neutrophilic dermatosis, acute febrile 10.4
38 psoriasis 14, pustular 10.4
39 achondroplasia, severe, with developmental delay and acanthosis nigricans 10.4
40 granuloma annulare 10.4
41 erythema multiforme 10.4
42 acquired generalized lipodystrophy 10.4
43 borderline leprosy 10.4
44 junctional epidermolysis bullosa 10.4
45 palmoplantar keratosis 10.4
46 necrobiosis lipoidica 10.4
47 porokeratosis 10.4
48 photoallergic dermatitis 10.4
49 phototoxic dermatitis 10.4
50 inverted follicular keratosis 10.4

Graphical network of the top 20 diseases related to Skin Conditions:



Diseases related to Skin Conditions

Symptoms & Phenotypes for Skin Conditions

UMLS symptoms related to Skin Conditions:


enanthema, exanthema, pruritus, skin manifestations, dry skin, nasal itching

Drugs & Therapeutics for Skin Conditions

Drugs for Skin Conditions (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 1337)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Tacrolimus Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 104987-11-3 445643 439492
2
Metformin Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 657-24-9 14219 4091
3
Acitretin Approved Phase 4,Phase 3,Phase 2,Not Applicable 55079-83-9 6437841 5284513
4
Benzocaine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 1994-09-7, 94-09-7 2337
5
Acetylcholine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 51-84-3 187
6
Ethanol Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 64-17-5 702
7
Petrolatum Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1 8009-03-8
8 Titanium dioxide Approved Phase 4,Phase 2,Not Applicable 13463-67-7
9
Ustekinumab Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 815610-63-0
10
Desonide Approved, Investigational Phase 4,Phase 3,Not Applicable 638-94-8 5311066
11
Esomeprazole Approved, Investigational Phase 4,Phase 1 161796-78-7, 119141-88-7 4594 9579578
12
Etanercept Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 185243-69-0
13
Methotrexate Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 1959-05-2, 59-05-2 126941
14
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1 22916-47-8 4189
15
Adalimumab Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 331731-18-1 16219006
16
Infliximab Approved Phase 4,Phase 3,Phase 2,Not Applicable 170277-31-3
17
Amorolfine Approved, Investigational Phase 4,Phase 3 78613-35-1
18
Ciclopirox Approved, Investigational Phase 4,Phase 3,Not Applicable 29342-05-0 2749
19
Coal tar Approved Phase 4,Phase 3,Not Applicable 8007-45-2
20
Chlorhexidine Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 55-56-1 9552079 2713
21
Phenol Approved, Experimental Phase 4,Not Applicable 108-95-2 996
22
Clindamycin Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 18323-44-9 29029
23
Clobetasol Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 25122-46-7, 25122-41-2 32798 5311051
24
Glycerol Approved, Investigational Phase 4,Phase 1,Not Applicable 56-81-5 753
25
Triamcinolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 124-94-7 31307
26
Aminolevulinic acid Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1 106-60-5 137
27
Isotretinoin Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 4759-48-2 5538 5282379
28
Salicylic acid Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1 69-72-7 338
29
Fexofenadine Approved, Investigational Phase 4,Phase 2 83799-24-0 3348
30
Gabapentin Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 60142-96-3 3446
31
Histamine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 75614-87-8, 51-45-6 774
32
Pregabalin Approved, Illicit, Investigational Phase 4 148553-50-8 5486971
33
Adapalene Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 106685-40-9 60164
34
Benzoyl peroxide Approved Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 94-36-0 7187
35
Imiquimod Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 99011-02-6 57469
36
Bosentan Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 147536-97-8 104865
37
Hydroquinone Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 123-31-9 785
38
Menthol Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 2216-51-5 16666
39
Zinc Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 7440-66-6 23994
40
Zinc oxide Approved Phase 4,Phase 3,Phase 2,Not Applicable 1314-13-2
41
Fluticasone Approved, Experimental, Investigational Phase 4,Not Applicable 90566-53-3 62924
42
Pimecrolimus Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 137071-32-0 6447131 17753757
43
Azelaic acid Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 123-99-9 2266
44
Iron Approved Phase 4,Phase 3,Phase 2,Early Phase 1,Not Applicable 7439-89-6 23925
45
Iodine Approved, Investigational Phase 4,Phase 2,Phase 1,Not Applicable,Early Phase 1 7553-56-2 807
46
Povidone Approved Phase 4,Phase 3,Phase 2,Not Applicable 9003-39-8
47
Povidone-iodine Approved Phase 4,Phase 3,Not Applicable 25655-41-8
48
Bacitracin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 1405-87-4 439542 10909430
49
Bronopol Approved Phase 4,Phase 3,Phase 2 52-51-7
50
Hydrocortisone Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 50-23-7 5754

Interventional clinical trials:

(show top 50) (show all 10000)
# Name Status NCT ID Phase Drugs
1 Comparison of Efficacy and Safety of 0.1% Tacrolimus and 0.1% Mometasone Furoate for Adult Vitiligo Unknown status NCT01333410 Phase 4 tacrolimus ointment;Mometasone furoate
2 Study of Efficacy of Metformin in the Treatment of Acanthosis Nigricans in Children With Obesity Unknown status NCT02438020 Phase 4 Metformin
3 Low-Dose (17.5 mg/Day) Acitretin: Comparable Efficacy Without the Side Effects? Unknown status NCT01228409 Phase 4 Acitretin 17.5 mg/day
4 Weight Reduction Alone May Not be Sufficient to Maintain Disease Remission in Obese Patients With Psoriasis Unknown status NCT01439425 Phase 4
5 The Use of Botulinum Toxin A in Two-Stage Tissue Expander/ Implant Breast Reconstruction Unknown status NCT01427400 Phase 4 Botulinum Toxin-A;Saline
6 Mometasone Furoate Cream Reduces Acute Radiation Dermatitis in Head and Neck Squamous Cell Carcinomas' Patients Unknown status NCT02495064 Phase 4 Mometasone Furoate Cream
7 The Difference of Microparticles in Patients With Psoriasis Vulgaris Who Received Stelara(Ustekinumab) Unknown status NCT02693470 Phase 4 Ustekinumab
8 Proton Pump Inhibitors Use in Patients With Psoriasis Unknown status NCT02624544 Phase 4 esomeprazole;desonide
9 Optimizing Psoriasis Treatment of Etanercept Combined Methotrexate Unknown status NCT02313922 Phase 4 etanercept combined with methotrexate or etanercept combined with placebo
10 Quality of Life of Patients With Psoriasis Treated With Methotrexate: Prospective, Randomized, Double-blind, Parallel Group Study. Unknown status NCT02248792 Phase 4 Methotrexate
11 Effects of Treatment With Biological Agents on Vascular and Cardiac Function in Psoriasis Unknown status NCT02144857 Phase 4 etanercept;ustekinumab;cyclosporine
12 A Study to Evaluate the Effectiveness of STELARA ™ (USTEKINUMAB) in the Treatment of Scalp Psoriasis Unknown status NCT01558310 Phase 4 Ustekinumab;Placebo
13 Study Evaluating the Efficacy and Safety of Triptergium Wilfordii and Acitretin in Psoriasis Vulgaris - CHINA201002016-2 Unknown status NCT01443338 Phase 4 Triptergium Wilfordii;Acitretin
14 Evaluation of Lymphocytic Infiltrate, Dendritic Cells and Cytokines Expression in Psoriatic Lesion and Normal Skin Before and After TNF Alfa Inhibitors Therapy Unknown status NCT01237262 Phase 4 Adalimumab, etanercept, infliximab
15 An Open-label Study to Evaluate the Efficacy of Re-treatment for Patients With a History of Etanercept Use Unknown status NCT01132235 Phase 4
16 Combining Acitretin and Efalizumab in the Therapy of Chronic Plaque Psoriasis Unknown status NCT00707070 Phase 4 efalizumab plus placebo;efalizumab plus acitretin
17 Home UVB Phototherapy for Psoriasis: Effectiveness, Quality of Life and Cost-Effectiveness Unknown status NCT00150930 Phase 4
18 Efficacy, Safety and Cost-effectiveness of a Sequential Therapy With RV4104A Ointment, Ciclopiroxolamine Cream and Ciclopirox Film-forming Solution Compared With Amorolfine Nail Lacquer in Dermatophytic Onychomycosis Unknown status NCT01014637 Phase 4 Amorolfine (Antifungal);RV4104A, Ciclopiroxolamine, Cyclopirox (Keratolytic Agents/Antifungal)
19 Study on the Effects of Oxygen-ozone Therapy on Back Pain in Subjects Aged 65 or Older Unknown status NCT01709058 Phase 4 Intramuscular/paravertebral injections of Oxygen-Ozone
20 Effectiveness of Lavage With Alcohol - Chlorhexidine for Chemical Matricectomy Unknown status NCT01844141 Phase 4 70% alcohol;70% alcohol - 0.5% clorhexidine
21 Efficacy & Safety of Clindamycin and Tretinoin in Acne Unknown status NCT01111994 Phase 4 Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel
22 Efficacy of Glycerol, Two Topical Steroids, and a Topical Immune Modulator Against Skin Irritation Unknown status NCT00779792 Phase 4 clobetasol;triamcinolone acetonide;tacrolimus;glycerol;vehicle ointment (paraffin oil/soft white paraffin)
23 Superficial Basal Cell Carcinoma Treatment With Topical Photodynamic Therapy With Fractionated 5-aminolevulinic Acid 20% Versus Two Stage Methylaminolevulinate Unknown status NCT01491711 Phase 4 Methylaminolevulinate PDT in 2 sessions;Fractionated 5-aminolevulinic acid hydrochloride 20% gel PDT
24 Efficacy and Safety of Low-dose Oral Isotretinoin for Seborrhea Unknown status NCT01139749 Phase 4 oral isotretinoin;salicylic acid and ciclopirox olamine
25 Efficacy and Safety of Treatment of Actinic Keratoses With Photodynamic Therapy Between MAL Cream and ALA Gel Unknown status NCT02647151 Phase 4 METHYLAMINOLEVULINATE HYDROCHLORIDE;AMINOLEVULINIC ACID HYDROCHLORIDE
26 Pregabalin for the Treatment of Uremic Pruritus Unknown status NCT01852318 Phase 4 pregabalin 75mg daily for 12 weeks;fexofenadine 60 mg daily for 12 weeks;placebo
27 Long Term Efficacy and Safety of Eryfotona AK-NMSC® in Patients With Actinic Keratosis Unknown status NCT01656226 Phase 4
28 Pilot Study of Tolerability and Effectivity of Two Combination Topical Acne Products Unknown status NCT02731105 Phase 4 Acnatac® Gel left face;Epiduo® Gel right face;Acnatac® Gel right face;Epiduo® Gel left face
29 Potential Effect of Topical Imiquimod on Atrial Ectopy in Patients With Actinic Keratosis Unknown status NCT01413763 Phase 4 Imiquimod cream 3.75%;Placebo cream
30 Efficacy of Pregabalin in the Management of Chronic Uremic Pruritus Unknown status NCT01073501 Phase 4 Pregabalin;Placebo
31 Safety and Tolerability of Acanya Gel in Combination With Atralin Gel for Acne Vulgaris Unknown status NCT01448733 Phase 4 Benzoyl peroxide 2.5%/clindamycin phosphate 1.2% in the morning with with tretinoin 0.05% gel in the evening
32 A Study Comparing Combination Clindamycin Phosphate/Tretinoin Gel Alone Versus With Benzoyl Peroxide Foaming Cloths for Facial Acne Unknown status NCT01422785 Phase 4 clindamycin phosphate 1.2%/tretinoin 0.025% gel alone;clindamycin phosphate 1.2%/tretinoin 0.025% gel plus benzoyl peroxide 6% foaming cloths
33 The Clinical And Subclinical Effects on Arterial Stiffness of Bosentan in Patients With Systemic Sclerosis Unknown status NCT02480335 Phase 4 bosentan
34 Clinical Study to Evaluate the Efficacy of Topical Medications Containing Benzoyl Peroxide and Sulfur in the Regression in the Short Time (24 Hours) of Moderate Acne Vulgaris Grade II (Pimples) Unknown status NCT01260571 Phase 4 Benzoyl peroxide and sulfur
35 Wound Management for Sacral Pressure Ulcers With Necrotic Tissue Unknown status NCT02224638 Phase 4
36 Efficacy of Quantum NPWT With Simultaneous Irrigation on Reduction of Wound Volume in Stage III/IV Pressure Ulcers. Unknown status NCT01734109 Phase 4
37 Clinical Trial of Hydroquinone Versus Miconazol in Melasma Unknown status NCT01661556 Phase 4 Miconazole;Hydroquinone
38 Olive Oil's Cream Effectiveness in Prevention of Pressure Ulcers in Immobilized Patients in Primary Care Unknown status NCT01595347 Phase 4 Hyper-oxigenated fatty acid
39 Trial Comparing Calmoseptine Ointment and Desitin Diaper Rash Paste in Diaper Dermatitis in Neonates and Infants Unknown status NCT02716415 Phase 4 Calmoseptine Ointment;Destin Maximum Strength 40% Zinc
40 Effect of Fluticasone Proprionate 0.05% on Narrow Band UV-B in Active Vitiligo Unknown status NCT01246921 Phase 4 Fluticasone proprionate 0.05% cream
41 Vitiligo and the Koebner Phenomenon (Model of Vitiligo Induction and Therapy: a Clinical and Immunological Analysis) Unknown status NCT01082393 Phase 4 topical tacrolimus treatment;topical pimecrolimus treatment;local mometasone furoate treatment;cold cream
42 Azelaic Acid Versus Hydroquinone in Melasma Unknown status NCT00927771 Phase 4 azelaic acid gel;hydroquinone cream
43 Imiquimod 3.75% Cream in Combination With Cryotherapy in the Treatment of Hypertrophic Actinic Keratoses Unknown status NCT01229319 Phase 4 Cryotherapy alone to Left arm plus cryotherapy + imiquimod to Right arm;Cryotherapy alone to Left arm plus cryotherapy + imiquimod to Right arm
44 Sienna+® Injection Time Study 4 Arms Unknown status NCT02612870 Phase 4
45 Wound Infections in Breast Cancer Surgery After Preoperative Skin Preparation With Chlorhexidine vs. Povidone-iodine Unknown status NCT02479347 Phase 4 Chlorhexidine;Povidone-Iodine
46 Clinical Evaluation of T.R.U.E. Test Allergens in Children an Adolescents Unknown status NCT01797562 Phase 4 T.R.U.E. Test Panel 3.2
47 Paclitaxel in Combination With Carboplatin Versus Paclitaxel Plus Epirubicin in Metastatic Breast Cancer Unknown status NCT02207361 Phase 4 Paclitaxel, Carboplatin;Paclitaxel, Epirubicin
48 Weekly and Every 3 Week Administration of Paclitaxel Liposome Injection in Metastatic Breast Cancer Unknown status NCT02142790 Phase 4 paclitaxel liposome injection
49 Safety and Efficacy of Clobetasol Propionate 0.05% E Foam in Alopecia Unknown status NCT01111981 Phase 4 Clobetasol Propionate 0.05% Emollient Foam
50 Proton MR Spectroscopy and 18F-Fluorocholine PET for Breast Cancer Diagnosis Unknown status NCT01956409 Phase 4 18F-FCH;Magnevist

Search NIH Clinical Center for Skin Conditions

Inferred drug relations via UMLS 73 / NDF-RT 51 :


Cell-based therapeutics:


LifeMap Discovery
Data from LifeMap, the Embryonic Development and Stem Cells Database
Read about Skin Conditions cell therapies at LifeMap Discovery.
Stem-cell-based therapeutic approaches for Skin Conditions:
BioDFactor
Stemedyne
Embryonic/Adult Cultured Cells Related to Skin Conditions:
Bone marrow-derived mesenchymal stem cells (Stemedyne PMIDs: 23295150

Genetic Tests for Skin Conditions

Anatomical Context for Skin Conditions

MalaCards organs/tissues related to Skin Conditions:

41
Skin, Breast, Testes, Lymph Node, Bone, Brain, T Cells

Publications for Skin Conditions

Articles related to Skin Conditions:

(show top 50) (show all 113)
# Title Authors Year
1
Correlations between skin hydration parameters and corneocyte-derived parameters to characterize skin conditions. ( 29603859 )
2018
2
An approach on the potential use of probiotics in the treatment of skin conditions: acne and atopic dermatitis. ( 29676446 )
2018
3
Improvement of skin conditions by ingestion of <i>Aspergillus kawachii</i> (Koji) extract containing 14-dehydroergosterol in a randomized, double-blind, controlled trial. ( 29563825 )
2018
4
Ultra-Low Dosage Regimen of Rituximab in Autoimmune Blistering Skin Conditions. ( 29720979 )
2018
5
Psychosocial adjustment to skin conditions resulting in visible difference (disfigurement): What do we know? Why don't we know more? How shall we move forward? ( 29872669 )
2018
6
A Randomized Controlled Trial Determining Variances in Ostomy Skin Conditions and the Economic Impact (ADVOCATE Trial). ( 29300287 )
2018
7
Amelioration of atopic-like skin conditions in NC/Tnd mice by topical application with distilled Alpinia intermedia Gagnep extracts. ( 28815692 )
2017
8
Millimeter-wave emissivity as a metric for the non-contact diagnosis of human skin conditions. ( 28836682 )
2017
9
Application of three hygrometers under different skin conditions in dogs: dry, moist and haired skin. ( 28868812 )
2017
10
Dermoscopy, Confocal Microscopy and other Non-invasive Tools for the Diagnosis of Non-Melanoma Skin Cancers and Other Skin Conditions. ( 28676883 )
2017
11
Common Skin Conditions in Children: Congenital Melanocytic Nevi and Infantile Hemangiomas. ( 28196319 )
2017
12
The impact of skin conditions on generic health-related quality of life. ( 28504391 )
2017
13
Nutritional Status and Habitual Dietary Intake Are Associated with Frail Skin Conditions in Community-Dwelling Older People. ( 28112767 )
2017
14
Context for Practice: Clinical Challenges Related to Rare and Uncommon Skin Conditions. ( 28682852 )
2017
15
Compassion focussed self-help for skin conditions in individuals with insecure attachment: A pilot evaluation of the acceptability and potential effectiveness. ( 28869774 )
2017
16
Associations between skin barrier characteristics, skin conditions and health of aged nursing home residents: a multi-center prevalence and correlational study. ( 29132305 )
2017
17
The Potential Psychological Impact of Skin Conditions. ( 28150109 )
2017
18
Common Skin Conditions in Children: Skin Infections. ( 28196318 )
2017
19
CMS MDS 3.0 Section M Skin Conditions in Long-term Care: Pressure Ulcers, Skin Tears, and Moisture-Associated Skin Damage Data Update. ( 28817452 )
2017
20
Inflammatory dermatoses, infections and drug eruptions are the most common skin conditions in hospitalized cancer patients. ( 29273489 )
2017
21
Dry skin conditions are related to the recovery rate of skin temperature after cold stress rather than to blood flow. ( 27917468 )
2017
22
Effects of intake of Lactobacillus casei subsp. casei 327 on skin conditions: a randomized, double-blind, placebo-controlled, parallel-group study in women. ( 28748132 )
2017
23
Patient-centred health care for people with chronic skin conditions. ( 28833008 )
2017
24
The cutaneous ecosystem: the roles of the skin microbiome in health and its association with inflammatory skin conditions in humans and animals. ( 28133874 )
2017
25
Common Skin Conditions in Children: Noninfectious Rashes. ( 28196317 )
2017
26
Common Skin Conditions in Children: Neonatal Skin Lesions. ( 28196316 )
2017
27
No-rinse mousse shampoos for skin conditions in dogs and cats. ( 28694380 )
2017
28
The role of adult attachment orientation and coping in psychological adjustment to living with skin conditions. ( 29274241 )
2017
29
CMS MDS 3.0 Section M Skin Conditions in Long-term Care: Pressure Ulcers, Skin Tears, and Moisture-Associated Skin Damage Data Update. ( 28817454 )
2017
30
Common Skin Conditions in Children: Foreword. ( 28196315 )
2017
31
Systematic mapping review about costs and economic evaluations of skin conditions and diseases in the aged. ( 27544020 )
2016
32
Parental, child, and adolescent experience of chronic skin conditions: A meta-ethnography and review of the qualitative literature. ( 27768987 )
2016
33
Inflammatory Skin Conditions Associated With Radiotherapy. ( 28010872 )
2016
34
Is education enough to improve quality of life in people with chronic inflammatory skin conditions? ( 27317274 )
2016
35
Age-Associated Skin Conditions and Diseases: Current Perspectives and Future Options. ( 26994263 )
2016
36
Skin conditions in a South African tuberculosis hospital: Prevalence, description, and possible associations. ( 27419379 )
2016
37
Cocoa Flavanol Supplementation Influences Skin Conditions of Photo-Aged Women: A 24-Week Double-Blind, Randomized, Controlled Trial. ( 26581682 )
2016
38
Fernblock (Polypodium leucotomos Extract): Molecular Mechanisms and Pleiotropic Effects in Light-Related Skin Conditions, Photoaging and Skin Cancers, a Review. ( 27367679 )
2016
39
Six years' experience of grenz ray therapy for the treatment of inflammatory skin conditions. ( 27747909 )
2016
40
Treating skin conditions in the community: know your emollients. ( 27594060 )
2016
41
Data on medicinal plants used in Central America to manage diabetes and its sequelae (skin conditions, cardiovascular disease, kidney disease, urinary problems and vision loss). ( 27761504 )
2016
42
The epidemiology of skin conditions in the aged: A systematic review. ( 27161662 )
2016
43
Skin conditions in veterinarians and veterinary workers: A worksite-based study. ( 27088939 )
2016
44
Skin conditions in children. ( 27180500 )
2016
45
Education to improve quality of life of people with chronic inflammatory skin conditions: a systematic review of the evidence. ( 26833102 )
2016
46
Skin conditions in veterinarians and veterinary workers: A worksite-based study. ( 26858051 )
2016
47
Implicit stigmatization-related biases in individuals with skin conditions and their significant others. ( 27505208 )
2016
48
Quality of life impact of childhood skin conditions measured using the Children's Dermatology Life Quality Index (CDLQI): a meta-analysis. ( 26686685 )
2016
49
Physiological and microbiological verification of the benefit of hair washing in patients with skin conditions of the scalp. ( 27229771 )
2016
50
Topical pine tar: History, properties and use as a treatment for common skin conditions. ( 26790564 )
2016

Variations for Skin Conditions

Expression for Skin Conditions

Search GEO for disease gene expression data for Skin Conditions.

Pathways for Skin Conditions

Pathways related to Skin Conditions according to GeneCards Suite gene sharing:

(show all 11)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
12.31 AIM2 CD247 IFNK TNF
2
Show member pathways
12.2 IFNK IL1A TNF
3
Show member pathways
11.92 CD247 IL1A TNF
4
Show member pathways
11.84 CD247 IL1A TNF
5
Show member pathways
11.29 IL1A TNF
6
Show member pathways
11.26 CD247 TNF
7 11.19 IL1A TNF
8 11.09 IL1A TNF
9 11.02 IL1A TNF
10 10.5 IL1A TNF
11 10.1 IL1A TNF

GO Terms for Skin Conditions

Cellular components related to Skin Conditions according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular space GO:0005615 9.43 IFNK IGFL1 IGFL2 IGFL3 IL1A TNF
2 extracellular region GO:0005576 9.17 DCD IFNK IGFL1 IGFL2 IGFL3 IL1A

Biological processes related to Skin Conditions according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cytokine-mediated signaling pathway GO:0019221 9.5 IFNK IL1A TNF
2 humoral immune response GO:0006959 9.37 IFNK TNF
3 positive regulation of interleukin-6 production GO:0032755 9.26 IL1A TNF
4 negative regulation of extrinsic apoptotic signaling pathway in absence of ligand GO:2001240 9.16 IL1A TNF
5 positive regulation of cytokine secretion GO:0050715 8.96 IL1A TNF
6 positive regulation of protein localization to cell surface GO:2000010 8.62 CD247 TNF

Molecular functions related to Skin Conditions according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cytokine activity GO:0005125 8.8 IFNK IL1A TNF

Sources for Skin Conditions

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....